World's Best Scientists 2026 revealed!
Erlend B. Smeland

Erlend B. Smeland

D-Index & Metrics

Biology and Biochemistry

D-Index
69
Citations
30023
World Ranking
7235
National Ranking
27

Overview

Erlend B. Smeland is affiliated with Oslo University Hospital in Norway and has contributed extensively to the field of medicine, specifically within oncology, pathology, and immunology. Their research spans a broad range of subfields including oncology, pathology and forensic medicine, immunology, cancer research, and genetics. The primary focus revolves around lymphoma diagnosis and treatment, CAR-T cell therapy research, and immune cell function and interaction.

The scientist's work covers several main topics, such as:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • T-cell and B-cell Immunology
  • Cancer Immunotherapy and Biomarkers
  • Viral-associated cancers and disorders
  • Immune Cell Function and Interaction
  • Cancer Genomics and Diagnostics

Among their recent papers are:

  • MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma, 2021, Haematologica
  • Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression, 2022, The Journal of Immunology
  • A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL, 2021, Blood Advances
  • Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma, 2023, Blood Advances
  • Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series, 2020, Blood Advances

Erlend B. Smeland has frequently published in the following venues:

  • Blood
  • Blood Advances
  • Haematologica
  • Journal of Biological Chemistry
  • The Journal of Immunology

They have collaborated often with coauthors, including:

  • June H. Myklebust
  • Harald Holte
  • Yngvild Nuvin Blaker
  • Ankush Sharma
  • Klaus Beiske

Best Publications

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

    R. Eric Davis;Vu N. Ngo;Georg Lenz;Pavel Tolar

  • Oncogenically active MYD88 mutations in human lymphoma

    Vu N. Ngo;Vu N. Ngo;Ryan M. Young;Roland Schmitz;Sameer Jhavar

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

    Georg Lenz;George W. Wright;N. C.Tolga Emre;Holger Kohlhammer

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

    Roland Schmitz;Ryan M. Young;Michele Ceribelli;Sameer Jhavar

  • Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma

    Georg Lenz;R. Eric Davis;Vu N. Ngo;Lloyd Lam

  • Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin embedded tissue

    David W. Scott;George W. Wright;P. Mickey Williams;Chih Jian Lih

  • Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction.

    Silvia Bea;Andreas Zettl;George Wright;Itziar Salaverria

  • EZH2 mutations are frequent and represent an early event in follicular lymphoma

    Csaba Bödör;Csaba Bödör;Vera Grossmann;Nikolay Popov;Jessica Okosun

  • Cooperative Epigenetic Modulation by Cancer Amplicon Genes

    Lixin Rui;N. C.Tolga Emre;Michael J. Kruhlak;Hye Jung Chung

  • Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival.

    Adrian Wiestner;Mahsa Tehrani;Michael Chiorazzi;George Wright

  • Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma

    Jagan R. Muppidi;Roland Schmitz;Jesse A. Green;Jesse A. Green;Wenming Xiao

  • Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma

    Georg Lenz;Inga Nagel;Reiner Siebert;Anna V. Roschke

  • Characterization of early stages of human B cell development by gene expression profiling

    Marit E. Hystad;June Helen Myklebust;June Helen Myklebust;Trond H. Bø;Einar A. Sivertsen

  • Expression of B-cell surface antigens in subpopulations of exosomes released from B-cell lymphoma cells.

    Morten P. Oksvold;Anette Kullmann;Lise Forfang;Lise Forfang;Bente Kierulf

Frequent Co-Authors

Jan Delabie
Jan Delabie University Health Network
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
Elias Campo
Elias Campo University of Barcelona
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
Heidi Kiil Blomhoff
Heidi Kiil Blomhoff University of Oslo
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Lisa M. Rimsza
Lisa M. Rimsza Mayo Clinic
German Ott
German Ott Robert Bosch (Germany)
Joseph M. Connors
Joseph M. Connors University of British Columbia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry often opens the door to a variety of related online degrees and dynamic career pathways. Students interested in how the body works, performance optimization, or rehabilitation may pursue an online exercise physiology degree. This pathway is ideal for those seeking flexible learning options while preparing for roles in sports, wellness, or clinical settings.

Another popular choice is a kinesiology online degree, focusing on movement science and overall physical health. Graduates can pursue careers in fitness training, physical therapy, or coaching, often catering to health-conscious individuals and athletes.

For those who wish to combine biology with advanced clinical practice, programs such as pmhnp online programs and post masters np program offer pathways towards psychiatric mental health and family nurse practitioner roles. These specialized certificates are perfect for nurses wanting to expand their expertise and meet growing healthcare demands via online study.

Whether your interests lean toward healthcare, sports science, or clinical practice, online degrees provide flexible options to grow your skills and advance your career.

Best Scientists Citing Erlend B. Smeland

Trending Scientists

Recently Published Articles